The global embolization coils market is estimated to exceed an amazing valuation of US$ 1,200 Million in 2022, with a compound annual growth rate (CAGR) of 5% projected from 2022 to 2032. Embolisation coils are used to treat aneurysms of the brain and heart, as well as other blood-related diseases.
The field of medical devices has witnessed remarkable advancements over the years, and embolization coils have become a significant player in this arena. This article delves into the insights surrounding the Embolization Coils market, exploring its growth trajectory, the opportunities it presents, the demand and supply trends, notable developments, and the intricacies of its value chain.
Get Free Sample Copy of This Report-https://www.factmr.com/connectus/sample?flag=S&rep_id=8070
Embolization Coils Market Growth
Cardiovascular diseases (CVDs) encompass conditions like cerebrovascular disease, coronary heart disease, and rheumatic heart disease. Risk factors such as tobacco use, an unhealthy diet, and physical inactivity heighten the chances of heart attacks and strokes. CVDs stand as the leading global cause of death, affecting more people than any other ailment. The prevalence of cardiac aneurysms is increasing worldwide, notably in individuals aged over 55. These aneurysms result from blockages in the aortic artery and are categorized as thoracic or abdominal aortic aneurysms, contributing to the growth of the embolization coils market.
Embolization Coils Market Opportunities
In a healthcare landscape that values patient-centric approaches and minimally invasive procedures, embolization coils offer a world of opportunities. Their use in treating a wide range of conditions, from cerebral aneurysms to uterine fibroids, positions them as versatile medical devices. As technology continues to advance, there is room for innovation in materials and design, presenting opportunities for manufacturers to create coils that are even more effective and safe for patients.
Key Companies Profiled In This Report
- Terumo Corporation
- Medtronic plc
- Boston Scientific Corporation
- Stryker Corporation
- KANEKA CORPORATION
- MicroPort Scientific Corporation
- Penumbra, Inc.
- Cook Medical LLC
- Johnson & Johnson Services, Inc.
- Shape Memory Medical INC
Embolization Coils Market Demand & Supply Trends
The demand for embolization coils is closely linked to the prevalence of vascular conditions and the adoption of minimally invasive procedures. Healthcare providers are increasingly opting for embolization as a preferred method for addressing certain medical conditions due to its reduced recovery time and lower risk. This surge in demand has led to advancements in the manufacturing of embolization coils, resulting in more options for healthcare professionals. However, the market faces challenges related to ensuring a consistent supply of high-quality coils to meet the growing demand.
Embolization Coils Market Notable Developments
Recent notable developments in the Embolization Coils market include the introduction of bioresorbable coils, which dissolve in the body over time, eliminating the need for long-term implantation. Additionally, advancements in imaging technologies have improved the precision and safety of embolization procedures. Furthermore, ongoing research and clinical trials are expanding the applications of embolization coils, indicating a dynamic and evolving market.
Embolization Coils Market Value Chain
The Embolization Coils market's value chain encompasses various stages, from research and development to manufacturing, distribution, and patient care. Manufacturers invest in research to develop innovative coil designs, which are then produced using advanced materials and technologies. These coils are distributed through healthcare supply chains to medical facilities, where interventional radiologists and clinicians utilize them for patient care. The value chain is completed when patients receive effective treatment using embolization coils, highlighting the interconnected nature of the medical device industry.
Market Competition
In July 2021, Terumo Medical Corporation (TMC) unveiled the AZUR Vascular Plug, a groundbreaking innovation compatible with microcatheters, designed for occluding arteries up to 8mm in diameter. This addition significantly bolsters Terumo's embolization portfolio, serving to reduce or block blood flow in peripheral vasculature arteries.
April 2021 marked the FDA approval of Medtronic PLC's Pipeline Flex Embolization Device with Shield Technology, primarily intended for treating brain aneurysms. Shield Technology enhances the flow diverter by reducing thrombogenicity, enhancing patient safety.
In August 2022, MicroPort Scientific Corporation secured approval from the Colombian Institute for Drug and Food Surveillance (INVIMA) for its revolutionary MinosTM Abdominal Aortic Stent-Graft and Delivery System. Developed independently by Endovastec™, this innovative system is tailored for treating infrarenal aortic aneurysms and stands out as the first domestically manufactured stent-graft system. It boasts an ultra-low profile delivery system with a mere 14F outer diameter.
Boston Scientific Corporation, on the other hand, offers the Pushable 0.018” and 0.035” Embolization Coils, which form a crucial part of their systematic approach to embolization. These coils, namely the VortX 18 and 35 Vascular Occlusion Coils, are uniquely designed with a proprietary conical shape and apex-first deployment. They are engineered to provide efficient embolization and complete vascular occlusion in a compact form.
Key Segments Profiled in the Embolization Coils Market Industry Survey
- By Type:
- Detachable Coil
- Pushable Coil
- By Application:
- Neurology
- Cardiology
- Urology
- Oncology
- Peripheral Vascular Disease
- Other
- By End-user:
- Hospitals
- Cardio Center
- Ambulatory Center
- Others
- By Material:
- Platinum
- Platinum & Hydrogel
- Platinum Tungsten Alloy
- By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa (MEA)
Get Customization on this Report for Specific Research Solutions –https://www.factmr.com/connectus/sample?flag=RC&rep_id=8070
The Embolization Coils market is a dynamic sector within the healthcare industry, offering innovative solutions for a wide range of vascular conditions. Its growth is fueled by the increasing adoption of minimally invasive procedures and a continuous quest for safer and more effective medical devices. As notable developments and advancements continue to shape the market, the value chain plays a pivotal role in ensuring that patients benefit from these cutting-edge technologies. The Embolization Coils market is not only a testament to medical innovation but also a reflection of the industry's dedication to improving patient outcomes and quality of life.
About Fact.MR:
Fact.MR is a distinguished market research company renowned for its comprehensive market reports and invaluable business insights. As a prominent player in business intelligence, we delivers deep analysis, uncovering market trends, growth paths, and competitive landscapes. Renowned for its commitment to accuracy and reliability, we empowers businesses with crucial data and strategic recommendations, facilitating informed decision-making and enhancing market positioning. With its unwavering dedication to providing reliable market intelligence, FACT.MR continues to assist companies in navigating dynamic market challenges with confidence and achieving long-term success. With a global presence and a team of experienced analysts, FACT.MR ensures its clients receive actionable insights to capitalize on emerging opportunities and stay ahead in the competitive landscape.
Contact:
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com
